|
G |
Ap1s1 |
adaptor related protein complex 1 subunit sigma 1 |
decreases expression |
ISO |
Thioridazine results in decreased expression of AP1S1 mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr12:22,665,128...22,676,079
Ensembl chr12:22,665,112...22,676,075
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
increases expression |
ISO |
Thioridazine results in increased expression of ASAH1 mRNA |
CTD |
PMID:17175557 |
|
NCBI chr16:53,998,604...54,030,006
Ensembl chr16:53,998,560...54,040,836
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression |
ISO |
Thioridazine results in increased expression of ASNS mRNA |
CTD |
PMID:17175557 |
|
NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
Thioridazine results in increased activity of CASP3 protein |
CTD |
PMID:21035837 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Thioridazine results in decreased expression of CCND1 protein |
CTD |
PMID:21035837 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Cdc25a |
cell division cycle 25A |
increases phosphorylation |
ISO |
Thioridazine results in increased phosphorylation of CDC25A protein |
CTD |
PMID:21035837 |
|
NCBI chr 8:117,953,223...117,971,552
Ensembl chr 8:117,953,444...117,971,519
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
Thioridazine results in decreased expression of CDK4 protein |
CTD |
PMID:21035837 |
|
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
Thioridazine results in increased expression of CDKN1A protein |
CTD |
PMID:21035837 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
increases expression |
ISO |
Thioridazine results in increased expression of CDKN2A protein |
CTD |
PMID:21035837 |
|
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
|
|
G |
Ces1d |
carboxylesterase 1D |
multiple interactions |
ISO |
Thioridazine inhibits the reaction [CES1 protein results in increased hydrolysis of 4-nitrophenyl acetate]; Thioridazine inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate] |
CTD |
PMID:20097249 |
|
NCBI chr19:15,195,514...15,239,827
Ensembl chr19:15,033,108...15,239,821
|
|
G |
Crh |
corticotropin releasing hormone |
decreases expression |
ISO |
Thioridazine results in decreased expression of CRH mRNA |
CTD |
PMID:16205782 |
|
NCBI chr 2:104,459,999...104,461,863
Ensembl chr 2:104,459,999...104,461,863
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine; CYP1A2 protein results in increased metabolism of and results in increased activity of Thioridazine |
CTD |
PMID:19482014 PMID:23397584 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
multiple interactions decreases activity |
ISO |
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine Thioridazine results in decreased activity of CYP2C19 protein |
CTD |
PMID:15135088 PMID:23397584 |
|
NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions |
ISO |
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine; CYP2D6 protein results in increased metabolism of and results in increased activity of Thioridazine |
CTD |
PMID:19482014 PMID:23397584 |
|
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity |
ISO |
Thioridazine results in decreased activity of CYP2E1 protein |
CTD |
PMID:15135088 |
|
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
multiple interactions decreases activity |
ISO |
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine Thioridazine results in decreased activity of CYP3A4 protein |
CTD |
PMID:15135088 PMID:23397584 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Depp1 |
DEPP1, autophagy regulator |
increases expression |
ISO |
Thioridazine results in increased expression of DEPP1 mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 4:148,780,330...148,784,566
Ensembl chr 4:148,782,479...148,784,562
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
decreases phosphorylation |
ISO |
Thioridazine results in decreased phosphorylation of EIF4EBP1 protein |
CTD |
PMID:21035837 |
|
NCBI chr16:68,954,860...68,968,248
Ensembl chr16:68,954,875...68,968,248
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
increases expression |
ISO |
Thioridazine results in increased expression of FABP1 mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 4:99,063,181...99,066,957
Ensembl chr 4:99,063,181...99,066,954
|
|
G |
Fndc4 |
fibronectin type III domain containing 4 |
increases expression |
ISO |
Thioridazine results in increased expression of FNDC4 mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 6:26,387,284...26,389,524
|
|
G |
Gdpd3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
increases expression |
ISO |
Thioridazine results in increased expression of GDPD3 mRNA |
CTD |
PMID:17175557 |
|
NCBI chr 1:198,199,032...198,209,178
Ensembl chr 1:198,199,622...198,209,150
|
|
G |
Hpn |
hepsin |
increases expression |
ISO |
Thioridazine results in increased expression of HPN mRNA |
CTD |
PMID:15342952 |
|
NCBI chr 1:89,534,112...89,549,575
Ensembl chr 1:89,534,106...89,543,967
|
|
G |
Inhbe |
inhibin subunit beta E |
increases expression |
ISO |
Thioridazine results in increased expression of INHBE mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 7:70,641,423...70,642,848
Ensembl chr 7:70,640,075...70,643,169
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions decreases activity |
ISO |
Thioridazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Thioridazine results in decreased activity of KCNH2 protein |
CTD |
PMID:15671647 PMID:16278312 PMID:21158687 PMID:24052561 |
|
NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253
|
|
G |
LOC299277 |
similar to serine (or cysteine) peptidase inhibitor, clade A, member 3B |
increases expression |
ISO |
Thioridazine results in increased expression of SERPINA3 mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 6:127,871,895...127,888,287
Ensembl chr 6:127,872,666...127,886,540
|
|
G |
Lss |
lanosterol synthase |
increases expression |
ISO |
Thioridazine results in increased expression of LSS mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr20:12,844,522...12,870,474
Ensembl chr20:12,842,884...12,870,497
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
increases expression |
ISO |
Thioridazine results in increased expression of NR0B2 mRNA |
CTD |
PMID:17175557 |
|
NCBI chr 5:151,776,004...151,779,319
Ensembl chr 5:151,776,004...151,779,319
|
|
G |
Nupr1 |
nuclear protein 1, transcriptional regulator |
increases expression |
ISO |
Thioridazine results in increased expression of NUPR1 mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 1:194,767,484...194,769,519
Ensembl chr 1:194,767,474...194,769,524
|
|
G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
increases expression |
ISO |
Thioridazine results in increased expression of PHYH mRNA |
CTD |
PMID:15342952 |
|
NCBI chr17:77,287,580...77,304,482
Ensembl chr17:77,287,188...77,304,530
|
|
G |
Prl |
prolactin |
increases expression |
ISO |
Thioridazine results in increased expression of PRL protein |
CTD |
PMID:4065553 |
|
NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Thioridazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,318,025...48,360,219
Ensembl chr 1:48,317,995...48,360,261
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
decreases expression |
ISO |
Thioridazine results in decreased expression of SLC2A3 mRNA |
CTD |
PMID:15342952 |
|
NCBI chr 4:155,549,991...155,626,018
Ensembl chr 4:155,408,233...155,631,856 Ensembl chr 4:155,408,233...155,631,856
|
|
G |
Tagln |
transgelin |
decreases expression |
ISO |
Thioridazine results in decreased expression of TAGLN mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 8:50,222,895...50,228,369
Ensembl chr 8:50,222,896...50,231,357
|
|
G |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
increases expression |
ISO |
Thioridazine results in increased expression of WIPI1 mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr10:97,859,730...97,896,949
Ensembl chr10:97,859,727...97,896,525
|
|